SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : TELK -- Telik, Inc. -- Ignore unavailable to you. Want to Upgrade?


To: former_pgs who wrote (835)1/10/2007 1:44:31 PM
From: zeta1961  Respond to of 887
 
You're right..an aurora/vegf inhibitor..sorry bout that..yeah, I don't know whether it's the scientific community that's pushing keeping Telcyta alive or what..what's esp. troubling is that it's a worldwide trial..

I am pleased that they'll be presenting results at scientific meetings..the cash balance is pretty impressive although I have no desire to get back in..

Elisabeth



To: former_pgs who wrote (835)1/11/2007 12:21:02 AM
From: zeta1961  Respond to of 887
 
Fyi, AACR is in Los Angeles from April, 14-18..edit: ASCO in Chicago, June 01-05